TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10695381
Drug: Atrial natriuretic
Normalized name: Atrial natriuretic factor
DrugBank: Atrial natriuretic peptide (DB15591)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Atrial natriuretic hormone concentration in blood serum
Study: 19425819
Drug: Whole-body vibration
Normalized name: Insects (whole body), mite dermatophagoides farinae
Approvals — FDA: no, EMA: no, PMDA: no
Description: Whole-body vibration exercise (static and dynamic tasks) twice a week for six weeks
Study: 25942666
Drug: Body Cream
Normalized name: Udderly Smooth Body Cream
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Body Cream (moisturizer group)
Study: 25942666
Drug: Flare Treatment
Normalized name: Flarex
DrugBank: Fluorometholone (DB00324)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Flare Treatment
Study: 17287406
Drug: Elevated thyrotropin
Normalized name: Thyrotropin
DrugBank: Thyrotropin (DB15263)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Elevated thyrotropin receptor antibody
Study: 17287406
Drug: Thyroid hormone
Normalized name: Thyroid hormone
Approvals — FDA: no, EMA: no, PMDA: no
Description: Thyroid hormone state (including subclinical thyrotoxicosis)
Study: 8960832
Drug: Continuous intraperitoneal
Normalized name: Ivy Dry Super Continuous Spray
Approvals — FDA: no, EMA: no, PMDA: no
Description: Continuous intraperitoneal insulin infusion (CPII) for 12 months
Study: 6452833
Drug: Pulverized tablets
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Pulverized tablets of salbutamol, theophylline, and their combination
Study: 15221507
Drug: Taurine 3
Normalized name: Taurine
DrugBank: Taurine (DB01956)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Taurine 3 g/day for 7 weeks
Study: 21343579
Drug: Nitroglycerin ointment
Normalized name: Nitroglycerin Ointment
DrugBank: Nitroglycerin (DB00727)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Nitroglycerin ointment (15 mg/d)
Study: 15164191
Drug: 600 mg
Normalized name: mesna 600 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 600 mg slow-release valproic acid (VPA)
Study: 15164191
Drug: 200 mg
Normalized name: RNA 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 200 mg slow-release levodopa (LD) + 50 mg benserazid
Study: 2240530
Drug: Famotidine 20
Normalized name: famotidine 20 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Famotidine 20 mg orally the night before surgery and 20 mg intramuscularly 60 minutes before induction of anaesthesia
Study: 83189
Drug: Isoprinosine treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Isoprinosine treatment
Study: 16860976
Drug: Korean red
Normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Korean red ginseng (KRG) preparation (2 g/meal=6 g/day) for 12 weeks
Study: 11850287
Drug: GW 420867X
Normalized name: GW 468816
DrugBank: GW 468816 (DB05417)
Approvals — FDA: no, EMA: no, PMDA: no
Description: GW 420867X 100 mg
Study: 17257231
Drug: Glyceryl trinitrate
Normalized name: Glyceryl trinitrate
DrugBank: Nitroglycerin (DB00727)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Glyceryl trinitrate (GTN) infusion (0.5 microg/kg/min for 20 min)
Study: 19298364
Drug: Parecoxib 40
Normalized name: Parécoxib
DrugBank: Parecoxib (DB08439)
Approvals — FDA: no, EMA: yes, PMDA: no
Description: Parecoxib 40 mg i.v. (Group IIa, n=57)
Study: 9554680
Drug: Active treatment
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active treatment with chlorthalidone and atenolol (or reserpine)
Study: 10068849
Drug: Treatment for
Normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Treatment for 7 days
Study: 8495454
Drug: Domperidone 20
Normalized name: Domperidone
DrugBank: Domperidone (DB01184)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Domperidone 20 mg plus paracetamol 1 g
Study: 7890009
Drug: HELP-apheresis treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: HELP-apheresis treatment
Study: 22992296
Drug: 6-week nicotine
Normalized name: Nicotine
DrugBank: Nicotine (DB00184)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: 6-week nicotine patch only
Study: 23927381
Drug: Capsule containing
Normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Capsule containing fish oil (Control)
Study: 26205759
Drug: Tacrolimus with
Normalized name: Tacrolimus
DrugBank: Tacrolimus (DB00864)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tacrolimus with oral prednisolone (TAC*)
Study: 26840902
Drug: Sumatriptan NS
Normalized name: NS-2359
DrugBank: NS-2359 (DB05805)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sumatriptan NS 20 mg
Study: 25425730
Drug: Abiraterone acetate
Normalized name: ABIRATERONE ACETATE
DrugBank: Abiraterone (DB05812)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Abiraterone acetate (1000 mg/once daily) plus prednisolone (5 mg/twice daily)
Study: 2124732
Drug: Diazepam enema
Normalized name: diazepam Enema
Approvals — FDA: no, EMA: no, PMDA: no
Description: Diazepam enema (0.5 mg/kg bodyweight)
Study: 9797051
Drug: Tetracycline HCl
Normalized name: tetracycline HCl
DrugBank: Tetracycline (DB00759)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tetracycline HCl (TTC) 10 mg/ml
Study: 9857541
Drug: Ultrasound technique
Normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ultrasound technique for prosthetic treatment planning and observation
Study: 2821953
Drug: Nortriptyline hydrochloride
Normalized name: Nortriptyline Hydrochloride
DrugBank: Nortriptyline (DB00540)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nortriptyline hydrochloride and electroconvulsive therapy
Study: 27553623
Drug: Sham (placebo)
Normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sham (placebo) treatment
Study: 11789260
Drug: Jinshuibao capsule
Normalized name: Jinshuibao
DrugBank: Ophiocordyceps sinensis (DB19288)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Jinshuibao capsule (JSBC) for 48 weeks
Study: 8697308
Drug: 1.25 mg
Normalized name: menthol 1.25 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 1.25 mg ramipril
Study: 3034021
Drug: All doses
Normalized name: All Clear
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: All doses of ramipril
Study: 11345282
Drug: Mometasone furoate
Normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Mometasone furoate dry powder inhaler (MF-DPI) 400 microg twice daily
Study: 11345282
Drug: Mometasone furoate
Normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Mometasone furoate dry powder inhaler (MF-DPI) 200 microg twice daily
Study: 11345282
Drug: Mometasone furoate
Normalized name: Mometasone Furoate
DrugBank: Mometasone furoate (DB14512)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Mometasone furoate dry powder inhaler (MF-DPI) 100 microg twice daily
Study: 10503166
Drug: Lentinan 2
Normalized name: lentinan
DrugBank: Lentinan (DB13480)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Lentinan 2 mg i.v. once a week for eight weeks
Study: 7908246
Drug: Inhaled salbutamol
Normalized name: salbutamol
DrugBank: Albuterol (DB01001)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Inhaled salbutamol (200 micrograms)
Study: 9050956
Drug: Continuous intrathecal
Normalized name: Ivy Dry Super Continuous Spray
Approvals — FDA: no, EMA: no, PMDA: no
Description: Continuous intrathecal baclofen infusion (CIBI)
Study: 7267673
Drug: Cephalexin 500
Normalized name: cephalexin 500 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cephalexin 500 mg twice daily
Study: 18841288
Drug: 600 mg
Normalized name: mesna 600 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 600 mg clopidogrel and acetylsalicylic acid (ASA)
Study: 19825916
Drug: lactated Ringer's
Normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: lactated Ringer's (RL) solution
Study: 11212591
Drug: Tricyclic antidepressants
Normalized name: TRICYCLIC ANTIDEPRESSANTS
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tricyclic antidepressants
Study: 15217841
Drug: Weekly home
Normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Weekly home visits by community health aides for one year in addition to usual duties
Study: 11515711
Drug: Clarithromycin formulation
Normalized name: Clarithromycin
DrugBank: Clarithromycin (DB01211)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Clarithromycin formulation 1 and 2
Study: 8877335
Drug: Ulfon Lyoc
Normalized name: Dimethyl sulfone
DrugBank: Dimethyl sulfone (DB14090)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ulfon Lyoc in lyophilised tablet form (group 1; n = 40)
Study: 28027682
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (placebo ointment)
Study: 26581685
Drug: Milk-based protein
Normalized name: milk protein concentrate
Approvals — FDA: no, EMA: no, PMDA: no
Description: Milk-based protein matrix (0.165 g/kg body mass)
Study: 11435249
Drug: Fluticasone propionate
Normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Fluticasone propionate 100 microg twice a day
Study: 20062928
Drug: DZ-697b 60
Normalized name: DA-697b
DrugBank: DA-697b (DB06001)
Approvals — FDA: no, EMA: no, PMDA: no
Description: DZ-697b 60 mg
Study: 18048822
Drug: Both groups
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Both groups (high-dose and conventional-dose chemotherapy)
Study: 25512407
Drug: Vehicle control
Normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vehicle control (0 mg)
Study: 11731185
Drug: Estradiol valerate
Normalized name: Estradiol Valerate
DrugBank: Estradiol valerate (DB13956)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Estradiol valerate (2 mg) for 21 days
Study: 21093467
Drug: Preferred RP
Normalized name: RP-72
DrugBank: RP-72 (DB17156)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Preferred RP dose (1.8 ± 0.3 g/meal for spicy food users, 0.3 ± 0.1 g/meal for non-users)
Study: 21093467
Drug: 1 g
Normalized name: Molds 1 g
Approvals — FDA: no, EMA: no, PMDA: no
Description: 1 g red pepper (RP)
Study: 19179979
Drug: Magnesium sulfate
Normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Magnesium sulfate (30 mg/kg bolus, 500 mg/h infusion)
Study: 9829494
Drug: Subcutaneous rHuEpo
Normalized name: GlycoPEGylated™rHuEPO
DrugBank: NE-180 (DB05619)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Subcutaneous rHuEpo (100 U/kg)
Study: 28333187
Drug: Eldelumab 20
Normalized name: Eldelumab
DrugBank: Eldelumab (DB06116)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Eldelumab 20 mg/kg
Study: 28333187
Drug: Eldelumab 10
Normalized name: Eldelumab
DrugBank: Eldelumab (DB06116)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Eldelumab 10 mg/kg
Study: 2857265
Drug: Control diet
Normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control diet with lower polyunsaturated to saturated fat ratio and placebo supplement
Study: 1678031
Drug: Preincubation of
Normalized name: OIL OF CAMPHOR
Approvals — FDA: no, EMA: no, PMDA: no
Description: Preincubation of platelets with aspirin (10 mumol/l)
Study: 20619353
Drug: Indacaterol 300
Approvals — FDA: no, EMA: no, PMDA: no
Description: Indacaterol 300 μg
Study: 9708631
Drug: Megestrol acetate
Normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Megestrol acetate 160 mg daily (LMA)
Study: 9708631
Drug: Megestrol acetate
Normalized name: Megestrol Acetate
DrugBank: Megestrol (DB19378)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Megestrol acetate 480 mg daily (HMA)
Study: 22469418
Drug: Natural S-equol
Normalized name: S-equol
DrugBank: Equol (DB11674)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Natural S-equol (10 mg S-equol daily for 12 weeks)
Study: 24696094
Drug: Bitopertin 10
Normalized name: Bitopertin
DrugBank: Bitopertin (DB12426)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Bitopertin 10 mg/d
Study: 28058763
Drug: Serious hypoglycaemia
Normalized name: clotrimazole
DrugBank: Clotrimazole (DB00257)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Serious hypoglycaemia (combined treatment groups)
Study: 2182732
Drug: 7-day trimethoprim
Normalized name: Trimethoprim
DrugBank: Trimethoprim (DB00440)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: 7-day trimethoprim treatment
Study: 30648303
Drug: Usual REMS
Normalized name: carbamide peroxide
DrugBank: Carbamide peroxide (DB11129)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Usual REMS treatments alone (n=11)
Study: 7505351
Drug: Nitrendipine (NTR)
Normalized name: nitrendipine
DrugBank: Nitrendipine (DB01054)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Nitrendipine (NTR) 10 mg, adjusted to 20 mg if necessary
Study: 31356229
Drug: Eluxadoline 100
Normalized name: eluxadoline 100 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Eluxadoline 100 mg twice daily for 12 weeks
Study: 15126582
Drug: 2 or
Normalized name: CP-2 Oral Product
Approvals — FDA: no, EMA: no, PMDA: no
Description: 2 or 5 mg mifepristone daily for 120 days
Study: 19535229
Drug: Standard olanzapine
Normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Standard olanzapine tablets (SOT)
Study: 21246365
Drug: Active treatment
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active treatment methods
Study: 17323096
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no platelet gel and fibrin sealant)
Study: 31118595
Drug: Testosterone treatment
Normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Testosterone treatment
Study: 12803576
Drug: 150 mg
Normalized name: pectin 150 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 150 mg of extended-release aspirin (ERASA)
Study: 15452780
Drug: Epinephrine injection
Normalized name: epinephrine Injection
DrugBank: Epinephrine (DB00668)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Epinephrine injection (in polyps >= 2 cm)
Study: 25325911
Drug: Endovascular therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Endovascular therapy in the fifth protocol (n=46)
Study: 24787495
Drug: Sucrose supplementation
Normalized name: Sucrose
DrugBank: Sucrose (DB02772)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Sucrose supplementation (2 g/kg body weight)
Study: 19879555
Drug: Topical application
Normalized name: Talc Topical application Powder
Approvals — FDA: no, EMA: no, PMDA: no
Description: Topical application
Study: 30689759
Drug: Doxycycline (100
Approvals — FDA: no, EMA: no, PMDA: no
Description: Doxycycline (100 mg twice daily for 7 days)
Study: 637293
Drug: New formulation
Normalized name: TRIPROLIDINE HYDROCHLORIDE 1.25 mg in 1 mL ORAL SYRUP [HISTEX PD Drops New Formulation]
Approvals — FDA: no, EMA: no, PMDA: no
Description: New formulation of etomidate
Study: 27517842
Drug: Higher initial
Normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Higher initial opioid dose (mg/kg/hr of morphine equivalents)
Study: 20418724
Drug: Patient-selected treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Patient-selected treatment partner-assisted therapy (TPA)
Study: 18752863
Drug: Interferon-ribavirin therapy
Normalized name: Ribavirin
DrugBank: Ribavirin (DB00811)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Interferon-ribavirin therapy
Study: 2175354
Drug: canrenoate potassium
Normalized name: canrenoate potassium
DrugBank: Canrenoic acid (DB09015)
Approvals — FDA: no, EMA: no, PMDA: no
Description: canrenoate potassium at 200 mg/day
Study: 26395129
Drug: Purified Shilajit
Normalized name: RAYON,PURIFIED
Approvals — FDA: no, EMA: no, PMDA: no
Description: Purified Shilajit (250 mg twice a day for 90 days)
Study: 8964276
Drug: Lamotrigine 100
Normalized name: lamotrigine 100 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Lamotrigine 100 mg (LTG 100)
Study: 22068817
Drug: Chemotherapy regimen
Normalized name: Anacin Aspirin Regimen Pill
Approvals — FDA: no, EMA: no, PMDA: no
Description: Chemotherapy regimen according to ATP‐CRA (Group B)
Study: 31332820
Drug: Esomeprazole 40
Normalized name: esomeprazole 40 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Esomeprazole 40 mg twice daily for 3 days
Study: 9768932
Drug: Low-dose aprotinin
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose aprotinin (group A; n = 14)
Study: 12071235
Drug: Iontophoretic application
Normalized name: Sumatriptan Iontophoretic Transdermal System
Approvals — FDA: no, EMA: no, PMDA: no
Description: Iontophoretic application of lidocaine (60 mg)
Study: 101223
Drug: Propranolol 80
Normalized name: propranolol 80 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Propranolol 80 mg thrice daily
Study: 804952
Drug: All active
Normalized name: All Clear
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: All active treatments (Tolamolol, Propranolol, Practolol)
Study: 32949
Drug: Dummy preparations
Normalized name: cranberry preparation
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dummy preparations (control)
Study: 24308188
Drug: ZHUANG medicine
Normalized name: Medicaine Sting
Approvals — FDA: no, EMA: no, PMDA: no
Description: ZHUANG medicine mediated thread moxibustion (ZMMTM) combined with Sulfasalazine (SASP)
Study: 26120851
Drug: Interactive injection
Normalized name: Menin-mll interaction inhibitor ko 539
DrugBank: Ziftomenib (DB17171)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Interactive injection risk intervention
Study: 7509509
Drug: 5,000 units
Normalized name: Lapase, 1200 units-15,000 units-15,000 units oral capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: 5,000 units standard heparin given twice-daily
Study: 3207328
Drug: Size 12
Normalized name: GRISEOFULVIN,MICROSIZE 125MG CAP
Approvals — FDA: no, EMA: no, PMDA: no
Description: Size 12 G latex rubber balloon catheter
Study: 12395330
Drug: VPA-985 300
Normalized name: VPA
DrugBank: Valproic acid (DB00313)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: VPA-985 300 mg
Study: 10091762
Drug: Dose-dense arm
Normalized name: ARM-210
DrugBank: ARM-210 (DB16944)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dose-dense arm
Study: 2247670
Drug: Intratracheal lignocaine
Normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intratracheal lignocaine (4 ml, 4%)
Study: 16202481
Drug: Scopolamine 0.3
Normalized name: scopolamine 0.3 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Scopolamine 0.3 mg
Study: 3925478
Drug: Scopolamine 0.6
Normalized name: scopolamine 0.6 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Scopolamine 0.6 mg
Study: 19433666
Drug: Ginkgo biloba
Normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ginkgo biloba 120 mg twice a day
Study: 10767728
Drug: Mianserin 30-60
Normalized name: mianserin 30 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Mianserin 30-60 mg/day
Study: 1552056
Drug: Tretinoin emollient
Normalized name: Tretinoin Emollient Topical
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tretinoin emollient cream 0.05%
Study: 21875635
Drug: Non-adjuvanted whole
Normalized name: HYACINTHOIDES NON-SCRIPTA WHOLE
Approvals — FDA: no, EMA: no, PMDA: no
Description: Non-adjuvanted whole virion H1N1 vaccine
Study: 11109306
Drug: Cocarboxylase (CC)
Normalized name: Cocarboxylase
DrugBank: Cocarboxylase (DB01987)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cocarboxylase (CC) administration, 5 mg/kg body weight, 3 times a week for 12 weeks.
Study: 26708675
Drug: Cooling to
Normalized name: Castiva Cooling Topical Product
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cooling to a rectal temperature of 33·5°C for 72 h (standard treatment).
Study: 26056407
Drug: Patient medication
Normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Patient medication monograph only (PMMO)
Study: 10378820
Drug: Diltiazem XR
Normalized name: diltiazem Extended Release Oral Capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Diltiazem XR 200 mg
Study: 10378820
Drug: Diltiazem XR
Normalized name: diltiazem Extended Release Oral Capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Diltiazem XR 300 mg
Study: 24763156
Drug: Yoga therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Yoga therapy intervention (6-week program, twice weekly group classes and once weekly home practice)
Study: 20635633
Drug: Antihelminthic therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Antihelminthic therapy (400 mg albendazole, two doses)
Study: 23735180
Drug: Test sirolimus
Normalized name: Sirolimus
DrugBank: Sirolimus (DB00877)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Test sirolimus tablets
Study: 17582403
Drug: Headfirst sperm
Normalized name: herring sperm DNA
Approvals — FDA: no, EMA: no, PMDA: no
Description: Headfirst sperm injection
Study: 11874944
Drug: Troglitazone 200
Normalized name: troglitazone 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Troglitazone 200 mg once daily
Study: 29174079
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no surfactant administered, maintained on CPAP)
Study: 22142813
Drug: Griffonia Simplicifolia
Normalized name: Griffonia Simplicifolia Seed
Approvals — FDA: no, EMA: no, PMDA: no
Description: Griffonia Simplicifolia extract (5-hydroxytryptophan) administered via oral spray for 4 weeks
Study: 8074597
Drug: Pamidronate disodium,
Normalized name: Pamidronate Disodium, 3 mg/mL intravenous solution
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pamidronate disodium, 60 mg, over 24 hours
Study: 9848833
Drug: Topical anesthetic
Normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Topical anesthetic (one drop before lens insertion at fitting and dispensing visits)
Study: 17700049
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of nefazodone and IPT
Study: 11310450
Drug: Treatment for
Normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Treatment for secondary NHL